NATURE’S SUNSHINE PRODUCTS, INC. Proceeds from Long-Term Debt Issued
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Proceeds from Long-Term Debt Issued of $68.32 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2019-03-08
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from issuance of long-term debt for the quarter ending 2015-12-31 was -$1.20M.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from issuance of long-term debt for the quarter ending 2011-12-31 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from issuance of long-term debt for fiscal 2018 was $68.32M, a 256.14% increase from fiscal 2017.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from issuance of long-term debt for fiscal 2017 was $19.18M.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from issuance of long-term debt for fiscal 2016 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from issuance of long-term debt for fiscal 2015 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2018-12-31 | $68.32M 10-K · filed 2019-03-08 | ||
| 2017-12-31 | $19.18M 10-K · filed 2019-03-08 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-08 | ||
| 2015-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | |
| 2015-09-30 | $1.20M 10-Q · filed 2015-11-06 | ||
| 2014-12-31 | $0.00 10-K · filed 2016-03-14 | ||
| 2013-12-31 | $10.00M 10-K · filed 2016-03-14 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $10.00M 10-K · filed 2014-03-17 | |
| 2011-09-30 | $10.00M 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |